ATE235054T1 - Elisa testsystem zur bestimmung von substanzen, die die bindung zwischen ig e und dessen receptor inhibiert - Google Patents

Elisa testsystem zur bestimmung von substanzen, die die bindung zwischen ig e und dessen receptor inhibiert

Info

Publication number
ATE235054T1
ATE235054T1 AT96944649T AT96944649T ATE235054T1 AT E235054 T1 ATE235054 T1 AT E235054T1 AT 96944649 T AT96944649 T AT 96944649T AT 96944649 T AT96944649 T AT 96944649T AT E235054 T1 ATE235054 T1 AT E235054T1
Authority
AT
Austria
Prior art keywords
receptor
inhibit
binding
test system
elisa test
Prior art date
Application number
AT96944649T
Other languages
English (en)
Inventor
Manfred Auer
Franz Hammerschmid
Georg Stingl
Original Assignee
Novartis Erfind Verwalt Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Erfind Verwalt Gmbh filed Critical Novartis Erfind Verwalt Gmbh
Application granted granted Critical
Publication of ATE235054T1 publication Critical patent/ATE235054T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Plant Substances (AREA)
AT96944649T 1995-12-28 1996-12-23 Elisa testsystem zur bestimmung von substanzen, die die bindung zwischen ig e und dessen receptor inhibiert ATE235054T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9526599.7A GB9526599D0 (en) 1995-12-28 1995-12-28 Elisa test system
PCT/EP1996/005824 WO1997024617A1 (en) 1995-12-28 1996-12-23 Elisa test system

Publications (1)

Publication Number Publication Date
ATE235054T1 true ATE235054T1 (de) 2003-04-15

Family

ID=10786124

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96944649T ATE235054T1 (de) 1995-12-28 1996-12-23 Elisa testsystem zur bestimmung von substanzen, die die bindung zwischen ig e und dessen receptor inhibiert

Country Status (12)

Country Link
US (1) US6258549B1 (de)
EP (1) EP0882229B1 (de)
JP (1) JP2000502793A (de)
AT (1) ATE235054T1 (de)
AU (1) AU1305897A (de)
CY (1) CY2470B1 (de)
DE (1) DE69626860T2 (de)
DK (1) DK0882229T3 (de)
ES (1) ES2195037T3 (de)
GB (1) GB9526599D0 (de)
PT (1) PT882229E (de)
WO (1) WO1997024617A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU769954B2 (en) * 1996-11-26 2004-02-12 Heska Corporation Method to detect IgE
US5945294A (en) 1996-11-26 1999-08-31 Heska Corporation Method to detect IgE
US7759133B2 (en) * 1998-12-22 2010-07-20 Alk-Abello A/S Method of detecting and/or quantifying a specific IgE antibody in a liquid sample
EP1497654A4 (de) * 2001-08-13 2006-06-07 Chen Swey Shen Alex Immunoglobulin-e-vakzine und verwendungsverfahren dafür
US20060154372A1 (en) * 2004-12-21 2006-07-13 Arter Thomas C Providing additional motion in assays
WO2006121886A1 (en) * 2005-05-06 2006-11-16 Kalypsys, Inc. Automated compound screening using gel-permeation matrix and pin-based sample transfer
US20110256641A1 (en) * 2010-04-19 2011-10-20 Michael Ling Methods and Systems for Detecting Free IgE
CN110358738B (zh) * 2019-08-22 2021-08-13 中国食品药品检定研究院 一种稳定测定抗IgE抗体药物生物学活性的方法
CN110716055A (zh) * 2019-09-11 2020-01-21 天津医科大学 过敏原特异性免疫球蛋白e致病活性检测试剂盒
CN110716054A (zh) * 2019-09-11 2020-01-21 天津医科大学 一种血清亲细胞性免疫球蛋白e的定量检测试剂盒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935339A (en) * 1985-05-07 1990-06-19 Nichols Institute Diagnostics Delayed solid phase immunologic assay
US4962035A (en) 1987-12-01 1990-10-09 President And Fellows Of Harvard College DNA encoding IgE receptor alpha-subunit or fragment thereof
US5639660A (en) 1988-02-24 1997-06-17 Hoffmann-La Roche Inc. Polypeptide and DNA sequence corresponding to the human receptor with high affinity for IgE
CA2064953A1 (en) 1991-04-03 1992-10-04 John Joseph Rejman Immunoassay for immunoglobulins
DK137992D0 (da) * 1992-11-13 1992-11-13 Alk Lab As Fremgangsmaade til paavisning af et immunologisk aktivt stof i en proeve under anvendelse af et maerkningsstof
JPH0772150A (ja) * 1993-09-02 1995-03-17 Tonen Corp ＩｇＥの測定方法
DK0733207T3 (da) 1993-12-10 1998-04-20 Genentech Inc Fremgangsmåder til diagnose af allergi og screening af anti-allergi-terapeutika
US5962634A (en) * 1994-07-08 1999-10-05 Thomas Jefferson University IgE antagonists

Also Published As

Publication number Publication date
CY2470B1 (en) 2005-06-03
DK0882229T3 (da) 2003-07-14
US6258549B1 (en) 2001-07-10
EP0882229B1 (de) 2003-03-19
PT882229E (pt) 2003-07-31
ES2195037T3 (es) 2003-12-01
AU1305897A (en) 1997-07-28
DE69626860D1 (de) 2003-04-24
WO1997024617A1 (en) 1997-07-10
EP0882229A1 (de) 1998-12-09
GB9526599D0 (en) 1996-02-28
DE69626860T2 (de) 2003-12-04
JP2000502793A (ja) 2000-03-07

Similar Documents

Publication Publication Date Title
HUP0202532A2 (hu) Ko-stimulátor szignál-transzdukciós molekula (AILIM) elleni humán monoklonális antitest és gyógyászati alkalmazása
DE69632447D1 (de) Analysator zur Analyse von Urinbestandteilen
DK0943097T3 (da) Fremgangsmåde til at påvise IgE
ATE233813T1 (de) Veränderte immunglobuline für spezifische fc- epsilon rezeptoren
DE69638128D1 (de) Verfahren zu Chemokinrezeptor 88C
EP1361229A3 (de) Verwendung von Tyrosine Kinase (PYK2) zur Produktion von Antikörper
ATE425989T1 (de) Proteinreinigungsverfahren
ATE258560T1 (de) Antikörper die den monozyten chemolockstoff protein 1 (mcp-1) rezeptor (ccr2) binden
EP1712623A3 (de) Selektion von Proteinen unter Verwendung von RNA-protein-fusionen
NO982794L (no) Diagnostisering og behandling av AUR-1 og/eller AUR-2 relaterte lidelser
FI915150A7 (fi) Menetelmät, reagenssit ja testikäyttöpakkaukset biologisten yksiköiden alapopulaatioiden määrittämiseksi
ATE235054T1 (de) Elisa testsystem zur bestimmung von substanzen, die die bindung zwischen ig e und dessen receptor inhibiert
DE69418284D1 (de) Vorrichtung zur analyse von haptenen und ihre verwendung
WO1997012039A3 (en) Sh2-containing inositol-phosphatase
DK0948604T3 (da) Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet
DE69504959D1 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4
ATE198512T1 (de) Transfizierte zelllinien die autoantigene exprimieren und ihre verwendung in immunotests zur erkennung von autoimmunkrankheiten
DE69628847D1 (de) Testverfahren und testsatz zur diagnose von autoimmunerkrankungen
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil
ATE312914T1 (de) Rdgb-proteine
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
WO1996037610A3 (en) Cck-4, a receptor tyrosine kinase, and methods for diagnosis and treatment of cck-4 signal transduction disorders
DE60129719D1 (de) Screening-verfahren zum identifizieren von g-proteinen und anderen verbindungen,die die phosphodiesterase (pde)-aktivität beeinflussen
MX9704717A (es) Antigeno, anticuerpos y ensayo de diagnostico para la enfermedad de alzheimer.
DE69918128D1 (de) Mutierte gewebefaktor-inhibitor (tfpi), dna sequenz davon und verwendung zur erkennung von thrombotischen erkrankungen

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee